Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon
FDA clears ICE Aspiration System

FDA clears new catheter for peripheral blood clots

The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space. 

pharmaceutical drug approval process

American Heart Association thinks pharmacists can play a bigger role in AFib care

Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for AFib patients? 

Advanced artificial intelligence (AI) models can evaluate cardiovascular risk in routine chest CT scans without contrast, according to new research published in Nature Communications.[1] In fact, the authors noted, the AI approach may be more effective at identifying issues than relying on guidance from radiologists.

AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required

Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans. 

2 out of 5 AFib patients develop heart failure later in life

Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.

TAVR JenaValve Trilogy Heart Valve System pure AR

Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation

The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.

Cardiologist heart

Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair

How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview. 

pharmaceutical drug approval process

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy

The new gene therapy candidate is now one step closer to being approved by the FDA. 

Thumbnail

CT procedure shown to reduce need for invasive cardiac testing

In a study, CT-FFR was shown to reduce the need for invasive tests to measure coronary artery blockage from 74.5% to 25.5%.

Displaying 489 - 496 of 1946
Design by Adaptive Theme